WithdrawnNot applicableNCT04511793

Hepatic Artery Infusion (HAI) Program at Duke University

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Michael Lidsky, M.D.
Principal Investigator
Michael Lidsky, MD
Duke University
Intervention
Medtronic Synchromed II pump(device)
Eligibility
18-80 years · All sexes
Timeline
20202022

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04511793 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma

← Back to all trials